These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes. Anderson DG; Ferreira-Correia A; Rodrigues FB; Aziz NA; Carr J; Wild EJ; Margolis RL; Krause A Mov Disord Clin Pract; 2019 Apr; 6(4):302-311. PubMed ID: 31061838 [TBL] [Abstract][Full Text] [Related]
5. Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis. Suzuki F; Sato N; Ota M; Sugiyama A; Shigemoto Y; Morimoto E; Kimura Y; Wakasugi N; Takahashi Y; Futamura A; Kawamura M; Ono K; Nakamura M; Sano A; Watanabe M; Matsuda H; Abe O J Neurol Sci; 2020 Jan; 408():116545. PubMed ID: 31704285 [TBL] [Abstract][Full Text] [Related]
6. Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry. Anderson DG; Haagensen M; Ferreira-Correia A; Pierson R; Carr J; Krause A; Margolis RL Neuroimage Clin; 2019; 21():101666. PubMed ID: 30682531 [TBL] [Abstract][Full Text] [Related]
7. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea. Walters AS; McHale D; Sage JI; Hening WA; Bergen M Clin Neuropharmacol; 1990 Jun; 13(3):236-40. PubMed ID: 2141544 [TBL] [Abstract][Full Text] [Related]
8. A clinico-genetic study of psychiatric disorder in Huntington's chorea. Watt DC; Seller A Psychol Med; 1993; Suppl 23():1-46. PubMed ID: 8108531 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical substrates of rigidity and chorea in Huntington's disease. Storey E; Beal MF Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298 [TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Gut bacteria regulate the pathogenesis of Huntington's disease in Chongtham A; Yoo JH; Chin TM; Akingbesote ND; Huda A; Marsh JL; Khoshnan A Front Neurosci; 2022; 16():991513. PubMed ID: 36312028 [TBL] [Abstract][Full Text] [Related]
14. Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative? Malek N; Newman EJ Acta Neurol Scand; 2017 Jan; 135(1):25-33. PubMed ID: 27150574 [TBL] [Abstract][Full Text] [Related]
15. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs. Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566 [TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease. Serranilla M; Woodin MA Front Cell Neurosci; 2022; 16():876821. PubMed ID: 35360490 [TBL] [Abstract][Full Text] [Related]
18. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. Reuter I; Hu MT; Andrews TC; Brooks DJ; Clough C; Chaudhuri KR J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):238-41. PubMed ID: 10644798 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline. Reilmann R Mov Disord; 2013 Jul; 28(8):1030-3. PubMed ID: 23674480 [TBL] [Abstract][Full Text] [Related]
20. Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease. Parent M; Bédard C; Pourcher E Am J Neurodegener Dis; 2013; 2(3):221-7. PubMed ID: 24093085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]